SAKK – YOUNG ONCOLOGY ACADEMY - Was junge Onkologen von ESMO - EHA - ESTRO und ESP berichten — European Society for Medical Oncology (ESMO) Congress 2024
Improving Perioperative Outcomes in Gastrointestinal Cancer – Personal Highlights
Neoadjuvant therapies have the potential to increase R0 resectability and thereby improving surgical outcomes. Two recent phase II trials, PANDAS/PRODIGE 44 (1) and NICHE-2 (2), investigated neoadjuvant treatment approaches for borderline resectable pancreatic cancer and locally advanced mismatch-repair deficient (dMMR) colon cancer, respectively, with notable implications for clinical practice.